Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

RNA Interference

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...

RNA Interference

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...

siRNA - Small Interfering RNAs

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...

Experimental RNAi

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...

Viruses with RNA Genomes

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...

Inhibitors of Viral Protein Synthesis

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

CROI 2026: Basic Science Highlights From the 2026 Conference on Retroviruses and Opportunistic Infections.

Topics in antiviral medicine·2026

Same author

Proof-of-concept of host attribution of antimicrobial resistance genes using wastewater Hi-C metagenome sequencing.

Journal of water and health·2026

Same author

Wastewater SARS-CoV-2 and COVID-19 Hospital Admission and Mortality - A Controlled Experimental Study.

medRxiv : the preprint server for health sciences·2026

Same author

CROI 2025: Summary of Basic Science Research in HIV.

Topics in antiviral medicine·2025

Same author

Long term assessment of SARS-CoV-2 in wastewater and the transition to evaluate additional viral targets.

The Science of the total environment·2025

Same author

An observational cohort study evaluating PrEP reach, engagement and persistence through a community-based mobile clinic in Miami-Dade County, Florida.

Journal of the International AIDS Society·2024

Search research articles

Related Experiment Video

Updated: May 11, 2026

Isolation of Viral Replication Compartment-enriched Sub-nuclear Fractions from Adenovirus-infected Normal Human Cells

Isolation of Viral Replication Compartment-enriched Sub-nuclear Fractions from Adenovirus-infected Normal Human Cells

Published on: November 12, 2015

Modulation of HIV-1 replication by RNA interference.

Jean-Marc Jacque¹, Karine Triques, Mario Stevenson

¹Program in Molecular Medicine, University of Massachusetts Medical School, 373 Plantation Street, Worcester, Massachusetts 01605, USA.

|June 28, 2002

Summary

Small interfering RNA (siRNA) effectively inhibits HIV-1 replication by targeting and degrading viral RNA. This RNA interference mechanism prevents crucial steps in the HIV-1 life cycle, offering a potential therapeutic strategy.

More Related Videos

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy

Published on: September 5, 2016

Molecular Modulation by Lentivirus-Delivered Specific shRNAs in Endoplasmic Reticulum Stressed Neurons

Molecular Modulation by Lentivirus-Delivered Specific shRNAs in Endoplasmic Reticulum Stressed Neurons

Published on: April 24, 2021

Related Experiment Videos

Last Updated: May 11, 2026

Isolation of Viral Replication Compartment-enriched Sub-nuclear Fractions from Adenovirus-infected Normal Human Cells

Isolation of Viral Replication Compartment-enriched Sub-nuclear Fractions from Adenovirus-infected Normal Human Cells

Published on: November 12, 2015

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy

Published on: September 5, 2016

Molecular Modulation by Lentivirus-Delivered Specific shRNAs in Endoplasmic Reticulum Stressed Neurons

Molecular Modulation by Lentivirus-Delivered Specific shRNAs in Endoplasmic Reticulum Stressed Neurons

Published on: April 24, 2021

Area of Science:

Molecular Biology
Virology
Gene Silencing

Background:

RNA interference (RNAi) is a natural process for gene silencing.
Small interfering RNA (siRNA) triggers RNAi in mammalian cells.
HIV-1 replication involves complex steps susceptible to therapeutic intervention.

Purpose of the Study:

To investigate the efficacy of siRNA in inhibiting HIV-1 replication.
To determine if siRNA can target various regions of the HIV-1 genome.
To assess siRNA's potential for modulating the HIV replication cycle.

Main Methods:

Utilized synthetic and plasmid-derived siRNA duplexes.
Targeted siRNAs to multiple regions of the HIV-1 genome.
Assessed inhibition in human cell lines and primary lymphocytes.

Main Results:

Demonstrated significant inhibition of early and late HIV-1 replication steps.
Showed specific degradation of genomic HIV-1 RNA by siRNAs.
Prevented the formation of viral complementary-DNA intermediates.

Conclusions:

RNA interference via siRNA is a potent strategy for inhibiting HIV-1 infection.
Genomic HIV-1 RNA within replication complexes is susceptible to siRNA-mediated degradation.
siRNA technology holds promise for developing novel anti-HIV therapies.